Providers Coverage Costs Reference

51/51 states verified · 14/25 providers audited

Medicaid coverage

Hawaii: what Medicaid covers

Hawaii’s QUEST Medicaid program covers Wegovy for weight loss as a Tier 2 non-preferred brand, with prior authorization and a quantity limit. Zepbound and Saxenda are not named on the July 1, 2026 Preferred Drug List, so their status is unverified rather than a refusal, and members can ask the plan for an exception to a drug that is not listed.

Checked against the primary source August 27, 2026
What Medicaid in Hawaii covers, and the criteria that apply.
Drug Position Criteria
Semaglutide Prior authorization Wegovy is a Tier 2 non-preferred anti-obesity agent on the QUEST PDL, with prior authorization and a quantity limit
Tirzepatide not checked Zepbound is not named on the July 1, 2026 QUEST Preferred Drug List
Liraglutide not checked Saxenda is not named on the QUEST PDL; liraglutide appears only as Victoza, the diabetes product
If the answer is no. Around 45% of initial prior authorizations for these drugs are refused, and 35 to 45% of first-level appeals are overturned. A refusal is not the end of the process, and the cash-pay routes are priced on this site alongside it.

Sources

Every claim above is checked against the primary text, and the date is the day we last opened it.

  1. 1
    Preferred Drug List (PDL), Hawaii QUEST Program, effective July 1, 2026 (UnitedHealthcare Community Plan of Hawaii)

    UnitedHealthcare Community Plan of Hawaii (Hawaii QUEST Medicaid managed care program) Primary text read and checked Checked August 27, 2026